MedTrace Logo

Remote Ischemic Postconditioning in Humans

NCT01113008 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2015-01-21

Study results available
· View outcomes & findings →

Summary

The aim of this study is to evaluate the phenomenon of remote ischemic post-conditioning in humans. The minor myocardial damage associated with percutaneous revascularization procedures may be attenuated by producing controlled ischemia in the arms immediately after carrying out these procedures (remote ischemic post-conditioning). The justification and design of this clinical trial has been reported: Cardiology. 2011;119(3):164-9.

Conditions

  • Myocardial Reperfusion Injury

Interventions

PROCEDURE

Remote ischemic postconditioning

Patients assigned to remote ischemic postconditioning will undergo three 5-minute cycles of ischemia using a blood-pressure cuff at 200 mmHg, placed on the non-dominant arm, interrupted twice for 5 minutes with the cuff deflated

PROCEDURE

Control group

In the control group the procedure will be limited to placing a deflated blood-pressure cuff (pressure: 0 mmHg) for 25 minutes.

Sponsors & Collaborators

  • FUNDACIÓN IMABIS

    collaborator UNKNOWN

  • Red Temática de Investigación Cooperativa en Enfermedades Cardiovasculares

    collaborator UNKNOWN

  • Hospital Universitario Virgen de la Victoria

    lead OTHER

Principal Investigators

  • Manuel F Jiménez-Navarro, Doctor · Servicio Cardiología, Hospital Universitario Virgen de la Victoria

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-02-29
Completion
2012-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01113008 on ClinicalTrials.gov